Close Menu
    Hala DXBHala DXB
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Hala DXBHala DXB
    Home » MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
    PR Newswire

    MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

    September 26, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ — MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market.

    Rather than relying on a single trending ingredient, HYALMASS AQUATOX brings together five high-interest active ingredients — PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid — in one advanced aesthetic formulation.

    Five Powerful Actives. One Advanced Formula.

    Botulinum Peptide — designed to support a smoother, more refined skin appearance
    GHK-Cu — a copper peptide widely studied for skin conditioning and regeneration-related applications
    Succinic Acid — recognized for its role in skin revitalization and antioxidant-related activity
    PDRN — associated with skin regeneration and recovery
    Exosomes — increasingly recognized for their role in advanced skin rejuvenation approaches

    By combining these highly sought-after ingredients, HYALMASS AQUATOX aims to address the growing global demand for multifunctional, ingredient-driven aesthetic solutions.

    A New Chapter for the HYALMASS Portfolio

    The launch follows the growing international interest in HYALMASS AQUA EXOSOME, strengthening MAYPHARM’s expanding presence in the global aesthetic market.

    As demand for advanced skin rejuvenation products continues to develop, the market has also seen an increasing number of products adopting similar ingredient concepts, visual identities, and positioning. MAYPHARM therefore emphasizes the importance of product authenticity and authorized distribution when purchasing HYALMASS products.

    Distributors, aesthetic professionals, and customers are encouraged to verify the original manufacturer, authorized supply channel, packaging, and official product information before purchasing or using HYALMASS products.

    Innovation That Moves With the Market

    With HYALMASS AQUATOX, MAYPHARM continues to expand its portfolio around emerging aesthetic trends while combining multiple high-interest actives into a single product concept.

    Five actives. One formula. A new direction for advanced skin care.

    HYALMASS AQUATOX — Coming Soon.

    Choose the Original. Choose MAYPHARM.

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/maypharm-unveils-hyalmass-aquatox-a-next-generation-multi-active-skin-solution-for-the-global-aesthetic-market-302890709.html

    Related Posts

    Professor Vladimir Obradović Unanimously Elected President of IPMA World

    October 6, 2026

    GIGABYTE Showcases NVIDIA-Powered AI from Desktop to Enterprise Scale at Ai Everything Abu Dhabi 2026

    October 6, 2026

    Gnani AI Brings Ascent, Its Flagship Contact Center & CX AI Partner Program to the Middle East

    October 6, 2026

    Optro Establishes UAE Hub to Support Rapid Transition to Agentic GRC Across the Middle East

    October 6, 2026

    Docquity Extends Asian Healthcare Intelligence to Japan Through Deepened Strategic Partnership with exMedio

    October 6, 2026

    Applied Intuition Announces Collaboration with Nissan to Provide AI-Native Development Platform and Support AI-Defined Vehicle Development

    October 5, 2026
    Latest News

    DR Congo Ebola toll rises above 4,000 deaths

    October 5, 2026

    – The Ebola outbreak in the Democratic Republic of the Congo has reached 8,376 confirmed cases and 4,042 deaths. National health authorities reported the updated total on October 5 as transmission continued across several parts of the country. The epidemic

    Brent crude steadies after surge above $103

    October 5, 2026

    Appendix surgery tied to lower colorectal cancer diagnoses

    October 5, 2026

    Renault expands France EV push with €10 billion investment

    October 5, 2026

    South Korean inflation reaches 2.9 percent annual growth

    October 3, 2026

    Sheikh Mohamed bin Zayed hosts Senator Joni Ernst for talks

    October 3, 2026

    PM Narendra Modi commends pilot Smit Machchhar for bravery

    October 3, 2026

    EU unveils EUCCS plan for secure emergency communications

    October 1, 2026
    © 2026 Hala DXB | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.